CTIX Stock | News | Quote | Stock Forum | Sunday, November 10,

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2013 at 3:07 PM

$CTIX Cellceutix Corp. CTIX Company Overview

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!

Last Updated: Sunday, November 10, 2013 3:06:46 PM

Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.83
Previous Close 1.81 Open 1.81
Daily Range 1.85 - 1.81 52wk Range 2.47 - 0.92
Volume 99,934 Dividend N/A
Average Vol (3m) 232,267 Yield N/A
Cellceutix Corp. CTIX
Company Information

100 Cumming Center
Suite 151-B
Beverly, MA 01915

Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com

Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Cellceutix Corp. CTIX
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts

Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors

Not Available
Company Notes

Formerly=EconoShare, Inc. until 2-2008
Service Providers

Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States

Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC

Cellceutix Corp. CTIX
CTIX Security Details

Share Structure

Market Value1 $185,779,741 a/o Nov 08, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value 0.0001
Shareholders

Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data

Short Interest 111,185 (14%)
Oct 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)

West Coast Stock Transfer Inc.

Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations

Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)

Cellceutix Corp. CTIX Recent News

Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sep 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sep 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sep 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets

1
2
next >

CTIX Cellceutix Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Volkswagen Leasing's MXN 2.5B Move Through Bolsa

Reading the Fine Print in VW Leasing's Latest Move Let's get right into the weeds: Volkswagen Leasing's cranking out MXN 2.5 billion in long-term debt certificates. This maneuver ain't happening in a vacuum—it's powered by the intricate levers behind Greenberg Traurig's sharp legal mind. This isn't just another financial transaction; it's a strategically framed...

Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Kat Florence Hotels Offers Unique $20K Wine Tastings

Luxury Retreat Offering Free Rare Wine Tastings The world of high-end hospitality just got a bit more intoxicating, literally. As of October 20, guests at the Elora luxury retreat, part of the Kat Florence Hotels portfolio, can indulge in some of the most coveted wines on the planet—gratis. That's right, wine aficionados can thank Kat Florence's latest extravagant...

King City Gardens Debuts Third Dispensary in Cincinnati

Every corner of Cincinnati’s cannabis scene just got a little busier with King City Gardens opening up shop in Colerain Township. This move marks their third Garden Dispensary in Greater Cincinnati. It’s not just about adding another location, though. It’s King City’s way of cementing their local roots deeper into the city’s soil, rolling out a mix of...

Norwegian Bella™: A New Era in Luxury Cruising

Setting Sail with Norwegian Bella™ in 2028 When you hear about another cruise ship hitting the water, eye rolls might come naturally. But Norwegian Cruise Line's latest announcement adds a few twists worth noting. Today, the big news is that the Norwegian Bella™, the freshest face in NCL's innovative Prima Class, is now open for bookings. This beauty will start its...

Prosecco DOC Chef Residency Debriefs on Inaugural Year

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

NCD Debuts Tool for Medicare Advantage Dental Plans

NCD Takes a Stab at Simplifying Medicare Advantage Dental Plans Alright, let's cut through the clutter and get to what's what. NCD has rolled out a new tool for Medicare Advantage plans, specifically targeting the dental benefits part. This isn't just a fancy gadget, but a real tool built from CMS data to provide some clarity in the chaotic world of health plans. We've...

Freight Rebound Sparks Strategic M&A Opportunities

Is the Freight Recovery Here to Stay? Just when you thought trucking might have run out of gas, we're hitting a sharp turn back into growth town. For those of you dropping equity crumbs every which way but loose in the last few years, this freight lull has been brutal—like the hangover from hell. But Brown Gibbons Lang & Company’s fresh report now hints at a brighter...

ARPwave Therapy: A Game Changer For Patient Recovery

New Insights in Recovery with ARPwave Therapy Getting stuck in a rehab rut is not uncommon. That's where ARPwave therapy steps in, taking an innovative approach to healing by focusing on the nervous system's role in recovery. Props to Jeff Kessler from Maximum Health Physical Therapy for shedding light on this game-changing method during an insightful piece in...

Laredo Oil Eyes Big Gains in Argentina's Oil Play

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...